Sunstone Therapies to present data on the long-term efficacy of psilocybin therapy in cancer patients with major depressive disorder (MDD) at the ASCO 2023 Annual Meeting New 18-month follow-up data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results